In February 2015 the Athlete tested positive for the prohibited substances Prednisolone and Prednisone. Thereupon the French Athletics Federation (FFA) failed to render timely a decision and the case was referred to French Anti-Doping Agency (AFLD). Following notification the Athlete filed a statement in his defence.
The Athlete acknowledged that at the material time he daily had used Prednisolone as treatment for his diagnosed condition. He mentioned this medication on the Doping Control Form and produced a medical certificate of his physician in Kenya.
The AFLD determines that:
- The Athlete had committed an anti-doping rule violation;
- The violation was not intentional;
- He failed to produce a prescription, nor documents regarding his diagnosed condition;
- He mentioned his medication on the Doping Control Form;
- He acted with No Significant Fault or Negligence.
Therefore the AFLD decides on 21 January 2016 to impose a 6 month period of ineligibility on the Athlete.
